Listing analysis and research matching Lilly:
GE and Lilly ink cancer diagnostics linkup
In a sign of the accelerating convergence between treatments and diagnostics GE and Eli Lilly have announced a collaboration to develop in vitro diagnostic assays that may help predict cancer treatment response to targeted therapies.
BioPartnering 2008
The terms of a deal on offer, a partner's development expertise and their alliance management skills are the top drivers of alliance formation according to senior partnering business development executives in the pharmaceutical, biotechnology and medical devices industry and research institutes who participated in the BioPartnering 2008 survey.
